Evidence map›Paper›PMID 29359794›Full record

ArticleBritish journal of haematology2019

Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes.

Kathy L McGraw, Johnny Nguyen, Najla H Al Ali, Rami S Komrokji, David Sallman, Xiaohui Zhang, Jinming Song, Eric Padron, Jeffrey E Lancet, Lynn C Moscinski and 2 more

Open access · bronzeAbstract readLetter
In one paragraph

Article in British journal of haematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Aberrant Expression ofBioMed research international · 2019
    Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Kathy L McGrawDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.ORCID 0000-0001-9184-5399
Johnny NguyenDepartments of Hematopathology and Clinical Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Najla H Al AliDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Rami S KomrokjiDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
David SallmanDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Xiaohui ZhangDepartments of Hematopathology and Clinical Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Jinming SongDepartments of Hematopathology and Clinical Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Eric PadronDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Jeffrey E LancetDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Lynn C MoscinskiDepartments of Hematopathology and Clinical Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Alan F ListDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Ling ZhangDepartments of Hematopathology and Clinical Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Moffitt Cancer Center · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
NCI NIH HHS P30 CA076292
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Enhancer of Zeste Homolog 2 ProteinGene Expression Regulation, NeoplasticHematologic NeoplasmsMutationMyelodysplastic SyndromesNeoplasm ProteinsDisease-Free SurvivalFemaleHumansImmunohistochemistryMaleSurvival RateEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanNeoplasm ProteinsEZH2immunohistochemistrymutationmyelodysplastic syndromessurvival

Identifiers

PMID29359794
PMCPMC7771337
OpenAlexW2791446179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.